Description:Rabbit anti-human Twik-related potassium channel 1 protein (TREK-1) polyclonal antibody
Purification: Protein G affinity purified
Product Type:Primary antibody
Target Protein:TREK-1
Immunogen:A synthetic peptide (SASRERPGYTA) derived from the amino acid residue 4-14 of human TREK-1, conjugated with KLH for immunization
Specificity:This antibody reacts with the 47kDa TREK-1 in Jurkat cell extract.
Species Reacitvity:Human and other species with consensus TREK-1 peptide (SASRERPGYTA)
Source:Rabbit
Formulation:Lyophilized in pH 7.4, 0.01M PBS
Reconstitution:Double distilled water is recommended to adjust the final concentration to 1.00mg/mL.
Storage:Store at -20oC
Research Area:Life science research, stem cell factor signalling, cancer research
Background:
TWIK-related potassium channel 1(TREK-1), also known as K2P2.1, is a two pore domain gated potassium channel that is involved with pain reception. TREK-1 is highly expressed in small sensory neurons and is extensively colocalized with TRPV1. TREK-1 is sensitive to noxious stimuli including extracellular pH, temperature, mechanical force, osmotic pressure and other stimuli. TREK-1 is one of the targets for pain mediator and anaesthesia drug.
Application:
ELISA: The antibody (1:500,000 diluted) can detect the TREK-1 peptide coated on ELISA plate at 100ng/well.
Western blot: Dilute approx. 1:3,000 for using in Western blot to detect the 47kDa TREK-1 in Jurkat cell extract.
Fig.1 Western blot analysis of Jurkat cell extract using rabbit anti-trek1.
References:
If research is published using this product, please inform Anogen in order to cite the reference on this datasheet. Anogen will provide one unit of product in the same category as gratitude.
Product Specificity | pAb Rabbit anti-Human TREK-1 (K2p2.1) |
---|---|
Application | EIA, WB |
Size | 0.1 mg |
Anogen-Yes Biotech Laboratories Ltd.是一家位于加拿大密西沙加的生物技术公司。成立于1989年,我们30年来一直是高质量抗体基产品的骄傲供应商。我们提供300多种单克隆和多克隆抗体,以及60多种类型的ELISA试剂盒,用于研究,诊断和治疗应用。
作为一家专注于研究的公司,我们还开发了许多专有的诊断和治疗产品。我们的产品Abcream是一种有效的抗牛皮癣局部抗IL-8(CXCL8)单克隆抗体,已于2001年获得中国国家食品药品监督管理局(SFDA)的批准,并获得多项国际专利。我们的用于诊断目的的新生儿TSH ELISA试剂盒也已获得加拿大卫生部的许可。我们还启动了针对炎症,阿尔茨海默氏病和癌症的研究和开发产品。